JP2012525422A5 - - Google Patents

Download PDF

Info

Publication number
JP2012525422A5
JP2012525422A5 JP2012508721A JP2012508721A JP2012525422A5 JP 2012525422 A5 JP2012525422 A5 JP 2012525422A5 JP 2012508721 A JP2012508721 A JP 2012508721A JP 2012508721 A JP2012508721 A JP 2012508721A JP 2012525422 A5 JP2012525422 A5 JP 2012525422A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
composition according
amount
centerkin
therapeutically effective
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2012508721A
Other languages
English (en)
Japanese (ja)
Other versions
JP2012525422A (ja
JP5498571B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2010/032942 external-priority patent/WO2010127096A2/en
Publication of JP2012525422A publication Critical patent/JP2012525422A/ja
Publication of JP2012525422A5 publication Critical patent/JP2012525422A5/ja
Application granted granted Critical
Publication of JP5498571B2 publication Critical patent/JP5498571B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2012508721A 2009-04-30 2010-04-29 センタキンを用いた新規の治療方法 Active JP5498571B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US17425709P 2009-04-30 2009-04-30
US61/174,257 2009-04-30
PCT/US2010/032942 WO2010127096A2 (en) 2009-04-30 2010-04-29 Novel therapeutic treatments using centhaquin

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2014044799A Division JP5727642B2 (ja) 2009-04-30 2014-03-07 センタキンを用いた新規の治療方法

Publications (3)

Publication Number Publication Date
JP2012525422A JP2012525422A (ja) 2012-10-22
JP2012525422A5 true JP2012525422A5 (enExample) 2012-11-29
JP5498571B2 JP5498571B2 (ja) 2014-05-21

Family

ID=43032771

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2012508721A Active JP5498571B2 (ja) 2009-04-30 2010-04-29 センタキンを用いた新規の治療方法
JP2014044799A Active JP5727642B2 (ja) 2009-04-30 2014-03-07 センタキンを用いた新規の治療方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2014044799A Active JP5727642B2 (ja) 2009-04-30 2014-03-07 センタキンを用いた新規の治療方法

Country Status (10)

Country Link
US (2) US20120083447A1 (enExample)
EP (1) EP2424529B1 (enExample)
JP (2) JP5498571B2 (enExample)
CN (2) CN102458399B (enExample)
AU (1) AU2010241564B2 (enExample)
BR (1) BRPI1013903B1 (enExample)
CA (1) CA2759791C (enExample)
ES (1) ES2614813T3 (enExample)
PL (1) PL2424529T3 (enExample)
WO (1) WO2010127096A2 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010127096A2 (en) 2009-04-30 2010-11-04 Midwestern University Novel therapeutic treatments using centhaquin
PL2890376T3 (pl) * 2012-08-31 2018-05-30 Pharmazz, Inc. Sposoby i kompozycje do resuscytacji hipotensyjnej
US20170326166A1 (en) * 2014-10-17 2017-11-16 University Of Virginia Patent Foundation Compositions and methods for treating pituitary tumors
EP4364811A3 (en) * 2018-05-03 2024-07-10 Midwestern University Alterations in endothelin receptors following hemorrhage and resuscitation by centhaquin
US20220362239A1 (en) * 2021-05-11 2022-11-17 Pharmazz, Inc. Pharmaceutical composition and method for treatment of acute respiratory distress syndrome (ards) in coronavirus disease (covid-19)

Family Cites Families (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3954987A (en) * 1972-12-22 1976-05-04 Sandoz, Inc. 2-Alkyl-4-substituted amino-quinazolines and nitrates thereof in the treatment of myocardial shock
DE2421382A1 (de) 1974-05-03 1975-11-20 Council Scient Ind Res 1-substituierte 4-(beta-2-chinolylaethyl)- piperazine und deren 1,2,3,4-tetrahydrochinolinanaloge
JPS604186B2 (ja) 1974-05-13 1985-02-01 カウンシル、オブ、サイエンテイフイツク、アンド、インダストリアルリサーチ 1―m―トリル―4―(B―2―キノリエチル)―ピペラジンの製造法
US3983121A (en) 1974-07-01 1976-09-28 Council Of Scientific And Industrial Research 1-Substituted 4-(β-2-quinolylethyl)piperazines and 1,2,3,4-tetrahydroquinolyl-ethyl analogues thereof
DE2557784C2 (de) * 1975-12-22 1986-04-17 Hoechst Ag, 6230 Frankfurt Forskolin, Verfahren zu dessen Gewinnung und diese Verbindung enthaltende pharmazeutische Präparate
US4761417A (en) * 1982-05-14 1988-08-02 Maroko Peter R Compounds, compositions and method of treatments for improving circulatory performance
EP0126327A1 (en) 1983-04-26 1984-11-28 Frank J. Macri Norepinephrine potentiated pharmaceutical composition, ophthalmic solution and kit containing the same
US5055470A (en) 1989-06-01 1991-10-08 Bristol-Myers Squibb Co. Method of treatment of ischemia in brain
US5922681A (en) 1992-09-14 1999-07-13 Warner-Lambert Company Endothelin antagonists
US20040063719A1 (en) * 1998-08-26 2004-04-01 Queen's University At Kingston Combination therapy using antihypertensive agents and endothelin antagonists
US6545048B1 (en) 1999-06-29 2003-04-08 California Institute Of Technology Compositions and methods of treating cancer using compositions comprising an inhibitor or endothelin receptor activity
US6113915A (en) 1999-10-12 2000-09-05 Allergan Sales, Inc. Methods for treating pain
US6369114B1 (en) 1999-11-30 2002-04-09 Institute Of Critical Care Medicine Administration of an α2-adrenergic receptor agonist to enhance cardiopulmonary resuscitation
GB0013378D0 (en) 2000-06-01 2000-07-26 Glaxo Group Ltd Use of therapeutic benzamide derivatives
SE0004455D0 (sv) 2000-12-01 2000-12-01 Milos Pekny Method for neuron regeneration in the central nervous system
AU2002241736A1 (en) 2000-12-21 2002-07-01 Bristol-Myers Squibb Company Method for preventing or treating pain by administering an endothelin antagonist
US20030232787A1 (en) 2001-05-08 2003-12-18 Dooley David James Combinations of an endothelin receptor antagonist and an antiepileptic compound having pain alleviating properties or analgesic
WO2003009805A2 (en) 2001-07-23 2003-02-06 Brigham And Women's Hospital, Inc. Analgesic methods using endothelin receptor ligands
US7030082B2 (en) 2001-09-07 2006-04-18 Nobex Corporation Pharmaceutical compositions of drug-oligomer conjugates and methods of treating disease therewith
US7973064B2 (en) * 2001-11-27 2011-07-05 The Board Of Trustees Of The University Of Illinois Method and composition for potentiating an opiate analgesic
US7351692B2 (en) * 2002-06-19 2008-04-01 The Board Of Trustees Of The University Of Illinois Method and composition for potentiating the antipyretic action of a nonopioid analgesic
JP2006508086A (ja) 2002-10-24 2006-03-09 ザ ボード オブ トラスティーズ オブ ザ ユニバーシティ オブ イリノイ 固形腫瘍を予防および治療するための方法および組成物
GB0226931D0 (en) 2002-11-19 2002-12-24 Astrazeneca Ab Chemical compounds
CA2506850C (en) 2002-11-20 2014-05-13 Neuronova Ab Compounds and methods for increasing neurogenesis
US7906140B2 (en) 2004-06-17 2011-03-15 Virun, Inc. Compositions for mucosal delivery of agents
WO2008043102A2 (en) 2006-10-06 2008-04-10 Transition Therapeutics Inc. Vasoactive intestinal polypeptide compositions
JP2009506119A (ja) 2005-08-31 2009-02-12 ユニバーシティ オブ テネシー リサーチ ファウンデーション 選択的アンドロゲン受容体モジュレーターを用いる腎疾患、熱傷、創傷および脊髄損傷の処置
US9829494B2 (en) 2005-12-01 2017-11-28 Adrenomed Ag Methods of treatment using ADM antibodies
JP2009530407A (ja) 2006-03-23 2009-08-27 アミリン・ファーマシューティカルズ,インコーポレイテッド 代謝性疾患の治療用のエンドセリン及びエンドセリン受容体アゴニスト
US8623823B2 (en) 2007-08-21 2014-01-07 Midwestern University Methods for treatment of stroke or cerebrovascular accidents using an ETB receptor agonist
US20100189802A1 (en) 2007-08-21 2010-07-29 Scott And White Memorial Hospital And Scott, Sherwood, And Brindley Foundation Method for treatment of vascular hyperpermeability
CN101374259B (zh) 2007-08-22 2012-08-08 华为技术有限公司 实现多媒体彩铃和多媒体彩像业务的方法和装置
EP2165706A1 (en) 2008-09-18 2010-03-24 BioAlliance Pharma Treating Inflammatory Pain in Mucosa of the Oral Cavity Using Mucosal Prolonged Release Bioadhesive Therapeutic Carriers.
WO2010127096A2 (en) 2009-04-30 2010-11-04 Midwestern University Novel therapeutic treatments using centhaquin
US8980874B2 (en) 2009-04-30 2015-03-17 Midwestern University Method and composition for treating diabetic ketoacidosis
KR101743280B1 (ko) 2010-06-17 2017-06-02 얀센 파마슈티카 엔.브이. Ccr2의 사이클로헥실-아제티디닐 길항제
KR101418941B1 (ko) 2011-04-04 2014-07-15 서울대학교병원 엔도텔린을 유효성분으로 함유하는 허혈성질환 치료용 조성물
PL2890376T3 (pl) 2012-08-31 2018-05-30 Pharmazz, Inc. Sposoby i kompozycje do resuscytacji hipotensyjnej
US10561704B2 (en) 2013-07-08 2020-02-18 Midwestern University Compositions and methods for treating neuropsychiatric disorders using an endothelin-B receptor agonist
EP4364811A3 (en) 2018-05-03 2024-07-10 Midwestern University Alterations in endothelin receptors following hemorrhage and resuscitation by centhaquin

Similar Documents

Publication Publication Date Title
JP2013525444A5 (enExample)
JP2013032389A5 (enExample)
JP2016510326A5 (enExample)
JP2015501783A5 (enExample)
HRP20171648T1 (hr) Supstituirani piperidil-etil-pirimidin kao inhibitor grelin-o-acil-transferaze
JP2013518107A5 (enExample)
JP2012255026A5 (enExample)
JP2011516477A5 (enExample)
JP2013542247A5 (enExample)
JP2012144574A5 (enExample)
UA109991C2 (xx) Карбаматні сполуки, їх отримання і застосування
JP2012092110A5 (enExample)
MD4736B1 (ro) Compus policiclic de carbamoilpiridonă şi utilizarea farmaceutică a acestuia
JP2011518833A5 (enExample)
EA201490419A1 (ru) Соединения для лечения и профилактики респираторного синцитиального вирусного заболевания
JP2013520405A5 (enExample)
JP2013507408A5 (enExample)
JP2010222367A5 (enExample)
JP2015516419A5 (enExample)
MX2012000488A (es) Terapia de combinacion para el tratamiento de la diabetes.
JP2013166781A5 (enExample)
RU2013150861A (ru) Фармацевтическая композиция, содержащая производные глутаримидов, и их применение для лечения эозинофильных заболеваний
ME02405B (me) Spojevi pirazola као inhibitori sglt1
JP2012516348A5 (enExample)
JP2012525422A5 (enExample)